thumbnail
Deal MakingMinaris produces first batch of Bluebird's sickle cell therapyMinaris produces first batch of Bluebird's sickle cell therapy
Contract development and manufacturing organization (CDMO) Minaris has manufactured the first commercial batch of bluebird bio’s sickle cell disease drug Lyfgenia.